Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Xenon Therapy for Children With Autism Spectrum Disorder [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update notes that xenon gas inhalation therapy is being studied for children with autism spectrum disorder in Phase 1 and Phase 2, currently no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xenon gas inhalation therapy (xenon gas inhalation)

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: Autism Spectrum Disorder (ASD), Autism | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING